ImClone Systems
ImClone Systems is a biopharmaceutical company that was established in 1984. It is known for its development of targeted treatments for cancer. The company was acquired by Eli Lilly and Company in 2008.
History[edit | edit source]
ImClone Systems was founded by Samuel Waksal, a scientist and entrepreneur, in 1984. The company initially focused on the development of monoclonal antibodies to treat cancer. In 1992, ImClone Systems went public, trading on the NASDAQ stock exchange.
In 2001, the company submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for its lead product, Erbitux (cetuximab), a monoclonal antibody for the treatment of colorectal cancer. However, the FDA rejected the application in 2002, leading to a significant drop in the company's stock price.
In 2008, ImClone Systems was acquired by Eli Lilly and Company, a global pharmaceutical company, for $6.5 billion. Following the acquisition, ImClone Systems became a fully owned subsidiary of Eli Lilly and Company.
Products[edit | edit source]
ImClone Systems' most notable product is Erbitux, which was eventually approved by the FDA in 2004 for the treatment of colorectal cancer. Erbitux works by inhibiting the epidermal growth factor receptor (EGFR), a protein that is often overexpressed in cancer cells.
In addition to Erbitux, ImClone Systems has developed several other monoclonal antibodies for the treatment of various types of cancer. These include Necitumumab for the treatment of non-small cell lung cancer, and Ramucirumab for the treatment of gastric cancer and colorectal cancer.
Controversies[edit | edit source]
ImClone Systems has been involved in several controversies. The most notable of these is the insider trading scandal involving the company's founder, Samuel Waksal, and lifestyle guru Martha Stewart. In 2002, Waksal was arrested and charged with insider trading for attempting to sell his shares in ImClone Systems ahead of the FDA's rejection of the Erbitux BLA. Stewart was also implicated in the scandal and was later convicted of lying to investigators about her sale of ImClone Systems stock.
See also[edit | edit source]
This biopharmaceutical related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
